The culture supernatants were analyzed for protein content. of protein secretion so far known, as well as the epithelial cell invasion and induction of macrophage apoptosis usually exhibited by this bacterium. Furthermore, we show the first evidence for the detrimental effect of these compounds on T3SS needle assembly, as exhibited by increased numbers of T3S apparatuses without needles or with shorter needles. Therefore, the compounds generate a phenocopy of T3SS export apparatus mutants but with incomplete penetrance. We discuss why this would be sufficient to almost completely block the later secretion of effector proteins and how this begins to thin the search for the molecular target of these compounds. Type III secretion systems (T3SSs) are key determinants of virulence in many gram-negative bacteria (10) that are pathogenic for plants, animals, and humans. These systems mediate a complex membrane transport process that directly delivers VU6005649 bacterial proteins across three biological membranes into host cells to enable bacterial infection. Major human pathogens that employ T3SSs for contamination includeShigella,Salmonella,Chlamydia,Yersinia, andPseudomonasspecies and enteropathogenicEscherichia coli. We study the pathogenesis ofShigella flexneri. Shigellacauses bacillary dysentery in humans, a disease characterized by invasion of, massive inflammation in, and destruction of the colonic mucosa. The genes required for invasion are clustered on a 31-kb region of a large virulence plasmid. There, themxiandspaoperons encode the T3SS apparatus and theipaandipgoperons encode proteins known as effectors, five of which, IpaA to -D and IpgD, are abundantly secreted early in invasion (33). The T3SS apparatus comprises three unique substructures: a cytoplasmic bulb, Mouse monoclonal to 4E-BP1 a region spanning both bacterial membranes and a hollow needle protruding from your bacterial surface. These last two portions can be purified together and are termed the needle complex (NC) (5,21,44). The central 25- channel of the NC (9) is usually thought to serve as a conduit for effector protein secretion. T3SSs are activated only upon direct physical contact with host cells. A protein complex at the tip of the needle, consisting of IpaB and IpaD, is usually directly involved in sensing host cells and regulating secretion (12,31,36,42). Upon activation of the T3SS, IpaC is usually recruited to the needle tip, and this prospects to insertion of the IpaBC translocon, which is required for translocation of the other early effectors into the plasma membrane of the host cell (42). TheShigellaT3SS displays three different functional states of protein secretion: (i) a burst of protein secretion, known as induction, upon host cell contact (25) or addition of an artificial inducer, the small amphipathic dye molecule Congo reddish (CR) (2); (ii) a low rate of protein secretion, termed leakage, prior to host cell contact (23); and (iii) constitutive secretion, which represents an unregulated and higher rate of secretion than leakage that occurs in some needle mutants (19) and IpaB or IpaD deletion strains (6,34,35,42). To battle the increasing antibiotic resistance of pathogenic bacteria, it will be crucial to develop new antimicrobial brokers. Strategies that rely on existing drugs and targets, which impact the viability of bacteria, all face the same problem, i.e., that bacteria quickly develop drug resistance under the huge selective pressure applied. The generation of drugs that specifically target pathogenic properties without killing bacteria is usually a strategy that might decrease the chance of bacterial resistance emerging against these drugs (20). Previously, in a large screening assay, small molecules that inhibit the expression of a virulence factor of theYersiniaT3SS without affecting the viability of the bacterial VU6005649 cell were recognized VU6005649 (18). In subsequent years, these and other related salicylidene acylhydrazides were found to inhibit secretion of T3SS-related proteins and to affect host cell contamination byYersinia,Chlamydia, andSalmonella(3,15,28-30,43). An overview of the T3SS-related inhibitory effects on analyzed pathogens for the compounds used in this work is usually given in Table1. Results are shown for T3SS-mediated protein secretion and in vitro virulence (pathogen replication, host cell contamination, and macrophage survival), which represent important assays to study T3SS activity. These T3SS inhibitors were also found to reduce the motility ofYersiniaandSalmonella(18,29) and to inhibit secretion and surface localization of flagellin inSalmonella(29). Taken together, these findings show that this inhibitors act on a conserved target, since they interfere with both the T3SS virulence determinant and the genetically related bacterial flagellar export system VU6005649 that mediates motility. == TABLE 1. == Overview of inhibitory effects of compounds in analyzed T3SS-carrying pathogens T3SS-mediated protein secretion or expression (the latter only for.